Improving ATTR-CM Care Through Community-Specialist Partnership

Guest: Alex Reyentovich, MD Community providers and amyloidosis specialists each play a vital role in diagnosing and managing transthyretin amyloid cardiomyopathy (ATTR-CM). Join Dr. Alex Reyentovich as he explains how this partnership can improve both patient care and diagnosis rates. Dr. Reyentovich is a Professor in the Department of Medicine at NYU Grossman School of Medicine and the Co-Director of the Amyloidosis Program at the Perlmutter Cancer Center at NYU Langone Health.